| ¿µ¹® | adrenal gland | ÇÑ±Û | ºÎ½Å |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀ§¿¡ Á¸ÀçÇÏ´Â ÇǶó¹Ô¸ð¾çÀÇ ±¸Á¶¹°. °ÑÁú°ú ¼ÓÁú·Î µÇ¾î ÀÖÀ¸¸ç È£¸£¸óÀÇ ºÐºñ°¡ ÁÖ¿ªÇÒÀÌ´Ù. ![]() |
||
| ¿µ¹® | hyperplasia | ÇÑ±Û | °ú´ÙÇü¼º, Áõ½Ä |
|---|---|---|---|
| ¼³¸í | ±â´ÉÇ×ÁøÀ» À¯¹ß½ÃŰ´Â ÀÚ±ØÀ» ¹Þ¾ÒÀ» ¶§ ºÐ¿ÀÌ °¡´ÉÇÑ ¼¼Æ÷°¡ ¼¼Æ÷ºÐ¿·Î ±× ¼ö°¡ Áõ°¡µÇ´Â °ÍÀ» Áõ½ÄÀ̶ó Çϸç, °á°úÀûÀ¸·Î ±× Á¶Á÷À̳ª Àå±âµµ Ä¿Áö°Ô µÈ´Ù. ºñ´ë´Â ´Ü¼øÈ÷ ¼¼Æ÷ÀÇ Áõ½ÄÀÌ ¾øÀÌ ¼¼Æ÷ÀÇ Å©±â°¡ Ä¿Áö´Â °æ¿ì¸¦ À̸£´Â ¸»ÀÌ´Ù. |
||
| ¿µ¹® | adrenal medulla | ÇÑ±Û | ºÎ½Å¼ÓÁú |
|---|---|---|---|
| ¼³¸í | ºÎ½ÅÀÇ ¾ÈÂÊ¿¡ ÀÖ´Â ºÎºÐÀ¸·Î ºÎ±³°¨½Å°æÀÇ Áö¹è¸¦ ¹Þ¾Æ¼ Ä«Å×Äݶó¹Î(catecholamine)À» ºÐºñÇÑ´Ù. |
||
| ¿µ¹® | Benign Prostatic Hyperplasia(BPH) | ÇÑ±Û | Àü¸³»ùºñ´ë |
|---|---|---|---|
| ¼³¸í | 50¼¼ ÀÌ»óÀÇ ³²¼º¿¡ ºó¹ßÇÏ´Â º´À¸·Î Àü¸³»ùÀÇ ¿äµµ ÁÖÀ§ ¿µ¿ª¿¡ Å«°áÀýÀ» Çü¼ºÇÏ¿©, À̰ÍÀÌ Ä¿Áö¸é ¿äµµ¸¦ ¾Ð¹ÚÇÏ¿© ºÎºÐÀû ȤÀº ¿ÏÀüÇÑ ¿äµµÆó»öÀ» ÀÏÀ¸Å°´Â º´ÀÌ´Ù. Áõ»óÀº ¿äµµÆó»ö¿¡ µû¸¥ ¼Òº¯ÀÇ °¨¼Ò¿Í ¹æ±¤ÀÚ±ØÁõ»óÀ¸·Î ºó´¢, ÀÜ´¢°¨, ¼Òº¯À» ÂüÀ» ¼ö ¾ø´Â Áõ»ó µîÀÌ´Ù. Ä¡·á´Â °æ¿äµµ Àü¸³»ù ÀûÃâ¼ú·Î Àü¸³¼±ÀÇ ºñ´ëÇÑ ºÎºÐÀ» ÀýÁ¦ÇØ¾ß ÇÑ´Ù. |
||
| ¿µ¹® | thymus(gland) | ÇÑ±Û | °¡½¿»ù |
|---|---|---|---|
| ¼³¸í | °¡½¿ÀÇ ¾Õ À§ÂÊ¿¡ À§Ä¡ÇÑ ¸²ÇÁ¼º Àå±â·Î¼, »çÃá±â¿¡ ÃÖ°íÀÇ ¹«°Ô¿¡ ´ÞÇß´Ù°¡ ÀÌÈÄ¿¡ ÅðÃàÇÑ´Ù. À̰ÍÀº ¼¼Æ÷¸Å°³ ¸é¿ª(cell-mediated immunity: ÁÖ·Î T-¸²ÇÁ±¸¿¡ ÀÇÇØ ÀϾ¸ç, ÀÚ±â¿Í ´Ù¸¥ ¼¼Æ÷¿¡ ´ëÇÑ Àνİú À̽İźιÝÀÀ¿¡ °ü¿©ÇÔ)±â´ÉÀÇ ¹ß´Þ°ú ¼º¼÷¿¡ ÇÊ¿äÇÑ Àå±âÀ̸ç, ȸ¹éÀû»öÀ¸·Î º¸Åë Á¤Á߸鿡¼ °áÇÕÁ¶Á÷¿¡ ÀÇÇØ °áÇÕµÈ µÎ °³ÀÇ ¿±À¸·Î µÇ¾î ÀÖ´Ù. °¡½¿»ùÀº »óÇǼ¼Æ÷, ¸²ÇÁ±¸, °¡½¿»ù¼¼Æ÷·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç Àü±¸¼¼Æ÷°¡ °¡½¿»ù¿¡ ÀÌÇàÇÏ¿© ¸²ÇÁ±¸·Î ºÐȵǰí, ±× ´ëºÎºÐÀº ÆÄ±«µÇ³ª ³ª¸ÓÁö´Â T¸²ÇÁ±¸¸¦ Çü¼ºÇÑ´Ù. °¡½¿»ùÀº ¶ÇÇÑ È£¸£¸ó À¯»ç¹°ÁúÀÎ thymine, thymopoietin, thymosin µîÀ» ºÐºñÇÑ´Ù. |
||
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
|---|---|
| HCG, hCG | Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó 1. Placental Glycoprotein Hormone &nbs... |
| CAH | 1) Chronic Active Hepatitis 2) Congenital Adrenal Hyperplasia |
| CAH | chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre... |
| CLAH | congenital lipoid adrenal hyperplasia |
| CAH | Cogenital adrenal hyperplasia |
|---|---|
| lipoid CAH | lipoid adrenal hyperplasia |
| AA | Adrenal androgen |
| AHC | Adrenal hypoplasia congenita |
| AI | Adrenal insufficiency |
| adrenal hyperplasia | <pathology> A condition of diffuse enlargement of the adrenal glands. Origin: Gr. Plassein = to form (27 Sep 1997) |
|---|---|
| adrenal hyperplasia, congenital | A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form. (12 Dec 1998) |
| congenital adrenal hyperplasia | <endocrinology> A genetic disorder present at birth characterised by a deficiency of the hormones aldosterone and cortisol and an overproduction of male sex hormones (androgens). In males this may manifest as enlarged penis, small testes and early development of masculine characteristics. In females features include ambiguous genitalia, failure to menstruate, deep voice and excessive hair. Origin: Gr. Plassein = to form (27 Sep 1997) |
| congenital virilizing adrenal hyperplasia | A series of inherited inborn errors of metabolism with hyperplasia of the adrenal cortex and overproduction of virilizing hormones. Most common forms are due to partial or complete 21-hydroxylase deficiency, leading to increased ACTH production by the pituitary, stimulating adrenal growth and function. Severe form is characterised by salt-losing state. (05 Mar 2000) |
| adrenal gland | <anatomy, endocrinology> This gland is found above each kidney and it made up of an outer wall (cortex) that secretes important steroid hormones and an inner portion (medulla) that produces adrenaline (adrenaline) and noradrenaline (noradrenaline). The hormones help control heart rate, blood pressure, the way the body uses food, and other vital functions. (25 Jun 1999) |
| adrenal gland hypofunction | Adrenocortical hypofunction includes all conditions in which adrenal steroid hormone secretion falls below the requirements of the body. Adrenal insufficiency may be divided into two general categories: (1) those associated with primary inability of the adrenal to elaborate sufficient quantities of hormone and (2) those associated with a secondary failure due to a primary failure in the elaboration of adrenocorticotropin. (12 Dec 1998) |
| adrenal gland insufficiency | <endocrinology> A condition that results from the inadequate production of adrenal hormones (see Addison's disease). (27 Sep 1997) |
| adrenal gland tumour | <oncology> A benign tumour or adenoma, that usually results in the excess production of adrenal gland hormones. (27 Sep 1997) |
| medulla of adrenal gland | It is composed principally of anastomosing cords of cells in the core of the gland; the cells display a chromaffin reaction because of the presence of epinephrine and norepinephrine in their granules. Synonym: medulla glandulae suprarenalis, medulla of adrenal gland. (05 Mar 2000) |
| angiofollicular mediastinal lymph node hyperplasia | Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma. Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease. (05 Mar 2000) |
| angiolymphoid hyperplasia with eosinophilia | Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells. (12 Dec 1998) |
| atypical melanocytic hyperplasia | Proliferation of melanocytes showing nuclear atypicality, especially as scattered single cells high in the epidermis; interpreted by some pathologists as malignant melanoma in situ. (05 Mar 2000) |
| basal cell hyperplasia | Increase in the number of cells in an epithelium resembling the basal cells. (05 Mar 2000) |
| benign giant lymph node hyperplasia | Solitary masses of lymphoid tissue containing concentric perivascular aggregates of lymphocytes, occurring usually in the mediastinum or hilar region of young adults; similar changes have been reported outside the mediastinum and, if associated with interfollicular sheets of plasma cells, may progress to lymphoma or plasmacytoma. Synonym: angiofollicular mediastinal lymph node hyperplasia, Castleman's disease. (05 Mar 2000) |
| benign prostatic hyperplasia | <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible. See: urinary retention. Origin: Gr. Plassein = to form (06 Aug 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|